AOBiome Targets Atopic Dermatitis Niche With Bacteria-Based Drug

 
• By Alaric DeArment
  
Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,
AOBiome announced Phase IIb data for its bacteria-based atopic dermatitis treatment, B244 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapy Areas